SISTEMA SEROTONÉRGICO Y SU IMPLICACION FARMACOLÓGICA EN PATOLOGÍAS CARDIOVASCULARES
Universidad de Salamanca
Salamanca, EspañaPublications in collaboration with researchers from Universidad de Salamanca (102)
2024
-
Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes
Biomedicine and Pharmacotherapy, Vol. 176
-
Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats
British Journal of Pharmacology
2023
-
Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats
Biomedicine and Pharmacotherapy, Vol. 153
-
Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats
International Journal of Molecular Sciences, Vol. 23, Núm. 10
-
Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes
Life Sciences, Vol. 293
2021
-
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Blood Cancer Journal, Vol. 11, Núm. 7
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Trends in the use of anxiolytics in castile and leon, spain, between 2015–2020: Evaluating the impact of covid-19
International Journal of Environmental Research and Public Health, Vol. 18, Núm. 11
-
Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment
Journal of Pharmacological Sciences, Vol. 147, Núm. 1, pp. 48-57
2020
-
Blockade of 5-HT2 receptors with sarpogrelate uncovers 5-HT7 receptors inhibiting the tachycardic sympathetic drive in pithed rats
Clinical and Experimental Pharmacology and Physiology, Vol. 47, Núm. 3, pp. 403-411
-
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Leukemia, Vol. 34, Núm. 6, pp. 1599-1612
-
Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge
Pflugers Archiv European Journal of Physiology, Vol. 472, Núm. 12, pp. 1693-1703
-
ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia
Cells, Vol. 9, Núm. 1
-
Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats
Scientific Reports, Vol. 10, Núm. 1
2019
-
Fluoxetine oral treatment discloses 5-HT 1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat
Canadian Journal of Physiology and Pharmacology, Vol. 97, Núm. 2, pp. 90-98
-
Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature
Hypertension Research, Vol. 42, Núm. 5, pp. 618-627
2018
-
Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow
Canadian Journal of Physiology and Pharmacology, Vol. 96, Núm. 4, pp. 328-336
2017
-
5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors
Clinical and Experimental Pharmacology and Physiology, Vol. 44, Núm. 12, pp. 1224-1231